-
Mashup Score: 0Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial - 3 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
The novel severe acute respiratory syndrome coronavirus 2, which causes a syndrome known as coronavirus 2019 (COVID-19), has been designated a global pandemic by the World Health Organization.1 The vast majority of patients with COVID-19 are advised to isolate and recuperate at home. The stay-at-home restrictions and limited access to ambulatory ophthalmology care inadvertently may delay the…
Source: OphthalmologyCategories: Latest Headlines, OphthalmologyTweet
Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial #BasalCell #Cancer #Patched #Smoothened #SMO #PTCH #Hedgehog #Orbit #Orbital #Tumor #Cancer #Lacrimal #Epiphora #VisualFunction https://t.co/TaRIIIoKcl https://t.co/2NLlXqfnr0